INDRAPRASTHA MEDICAL CORP Share Price

NSE: INDRAMEDCO
|
Healthcare Services

₹ 327.45

-₹2.50 (-0.76%)
1D
Last updated 14 Oct, 2026, 15:29 IST

INDRAPRASTHA MEDICAL CORP Share Price Today

As of 14 Oct 2026, INDRAPRASTHA MEDICAL CORP share price is ₹327.45. The stock opened at ₹331.00, compared to its previous close of ₹329.95. During today's trading session, INDRAPRASTHA MEDICAL CORP share price moved in the range of ₹326.30 to ₹331.70, with an average price of ₹329.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹317.15 and a high of ₹640.85. On the performance front, INDRAPRASTHA MEDICAL CORP share price has declined by 22.32% over the last six months and is down 41.80% on a year-on-year basis.

₹326.30
0.76% down today
₹331.70
1D LOW
1D HIGH

INDRAPRASTHA MEDICAL CORP Returns Calculator

Volume
78,915
Average traded price
₹328.88
Last traded time
03:29:56 14 Oct
Last traded quantity
3
Circuit
L
H
₹264.00
₹395.90
52-week
L
H
₹317.15
₹640.85
Mkt Cap Cr
3,039.88
P/E
16.11
P/B
4.09
ROA
18.96%
ROE
24.8%
ROCE
32.39%
Quick Ratio
2.41
EV/EBITDA
9.25
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Indrapr.Medical has not beaten FD return of 7%
Step 3 of 5
Valuation
Fairly Valued
Indrapr.Medical appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Apollo Hospitals1,12,225.3652.1211.949.79%20.48%17.27%0.9828.14
MANIPAL HEALTH ENTERPRI L87,860.6296.945.354.07%10.59%9.51%1.1735.11
Max Healthcare84,580.6657.687.828.46%13.42%12.97%0.8435.73
Aster DM Healthcare59,426.27165.6314.284.47%8.48%10.1%1.966.42
Fortis Healthcare57,074.8453.315.776.7%10.53%12.56%0.827.65
Global Health35,176.8962.378.79.35%14.05%15.26%2.5433.32
Narayana Hrudayalaya34,465.4542.27.596.55%17.76%11.42%2.0721.3
Dr. Lal Path Labs32,084.3058.7312.7917.36%20.13%25.56%3.3835.44
KRISHNA INST OF MED SCI L29,767.96153.087.942.51%10.74%7.99%0.6839.22
Poly Medicure16,207.7051.85.227.99%10.37%12.71%2.6229.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About INDRAPRASTHA MEDICAL CORP

ISIN
INE681B01017
Sector Market Cap
₹ 3,039.88 Cr

Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. It has approximately 52 specialties under one roof with the major specialties being anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics & gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, neurosciences, ophthalmology, orthopedics, otolaryngology (ENT), pediatrics, pediatric surgery, psychiatry and clinical psychology, rheumatology, spine surgery, urology and andrology and vascular and endovascular surgery.

INDRAPRASTHA MEDICAL CORP Financial Highlights

  • Revenue: INDRAPRASTHA MEDICAL CORP reported revenue of ₹1,511.26 crore in FY26 vs ₹1,379.01 crore in FY25. It showed an increase of 9.59% on a yearly basis.
  • Operating Profit: INDRAPRASTHA MEDICAL CORP reported an operating profit of ₹246.02 crore in FY26 vs ₹216.32 crore in FY25. It showed an increase of 13.73% on a year-on-year basis.
  • Net Profit: INDRAPRASTHA MEDICAL CORP reported a net profit of ₹183.62 crore in FY26 vs ₹160.99 crore in FY25. It showed an increase of 14.06% on a yearly basis.

INDRAPRASTHA MEDICAL CORP Quarterly Result Highlights

  • INDRAPRASTHA MEDICAL CORP reported revenue of ₹414.57 crore in Jun 2026, compared with ₹372.14 crore in Mar 2026, representing an increase of 11.40% on a quarter-on-quarter (QoQ) basis.
  • INDRAPRASTHA MEDICAL CORP reported an operating profit of ₹74.82 crore in Jun 2026, compared with ₹55.01 crore in Mar 2026, representing an increase of 36.01% on a quarter-on-quarter (QoQ) basis.
  • INDRAPRASTHA MEDICAL CORP reported a profit of ₹55.85 crore in Jun 2026, compared with ₹41.70 crore in Mar 2026, reflecting an increase of 33.93% on a QoQ basis.
  • The earnings per share (EPS) of INDRAPRASTHA MEDICAL CORP stood at ₹17.56 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
51.00%
FII
2.39%
Other DII
0.87%
Retail and other
44.84%
Mutual funds
0.91%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20252.73%
Mar 20262.44%
Jun 20262.77%
Sep 20262.39%
1 day
-0.38%
1 week
-1.55%
1 month
-7.06%
1 year
-41.80%
3 years
+89.74%
5 years
+312.44%
Day
Open / Close
Change %
13 Oct 26
₹327.25 / ₹329.95
-0.38%
12 Oct 26
₹329.00 / ₹331.20
+0.65%
09 Oct 26
₹320.00 / ₹329.05
+2.86%
08 Oct 26
₹329.40 / ₹319.90
-2.88%
Show more

INDRAPRASTHA MEDICAL CORP Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1,356.36₹1,244.70₹1,098.67₹888.16
Other Income₹22.65₹16.89₹10.03₹3.12
Total Revenue₹1,379.01₹1,261.59₹1,108.70₹891.28
Total Expenses₹1,162.69₹1,095.48₹991.52₹812.21
Profit Before Tax₹216.32₹166.11₹117.18₹79.07
Tax₹55.33₹42.15₹31.03₹20.45
Profit After Tax₹160.99₹123.96₹86.15₹58.62
EPS - Basic₹17.56₹13.52₹9.40₹6.39
EPS - Diluted₹17.56₹13.52₹9.40₹6.39

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹216.32₹166.11₹117.18₹79.07
Income before WC changes₹241.54₹191.53₹147.75₹117.27
Change in Assets-₹18.82₹14.79-₹21.95₹24.70
Change in Liabilities-₹4.98₹40.67₹28.61-₹28.15
Change in WC-₹23.80₹55.46₹6.66-₹3.45
Cash flow from Operations₹156.75₹200.15₹144.47₹94.30
Cash flow from Investing-₹110.99-₹158.43-₹107.91-₹74.11
Cash flow from Financing-₹45.88-₹32.38-₹26.04-₹3.37
Total Cash Flow-₹0.12₹9.34₹10.52₹16.82
Cash (Start of the year)₹61.60₹52.26₹41.74₹24.92
Cash (End of the year)₹61.48₹61.60₹52.26₹41.74

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹420.49₹415.26₹332.06₹304.28
Current Assets₹431.13₹307.98₹223.08₹157.43
Total Assets₹851.62₹723.24₹555.14₹461.71
Current Liabilities₹178.71₹165.42₹129.63₹93.50
Net Current Asset₹252.42₹142.56₹93.45₹63.93
Non-Current Liabilities₹76.23₹80.06₹46.06₹42.77
Equity Capital₹596.68₹477.76₹379.45₹325.44
Total Equity & Liabilities₹851.62₹723.24₹555.14₹461.71
* All values are in INR Crore
Qty
Bid
1
327.8
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 1
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
35.8
Neutral
ATR (14)
11.8
Neutral
STOCH(9,6)
30.62
Neutral
STOCH RSI (14)
30.17
Neutral
ADX(9)
42.56
Bearish
UO(9)
48.01
Neutral
ROC(12)
-10.94
Bearish
WillR(14)
-79.62
Neutral
Period
Simple value
Exponential vaue
5D
327.9
330.64
10D
335.09
335.92
20D
349.31
344.24
50D
360.12
356.52
100D
369.52
366.72
Volume trend — traded volume by day
14 Oct0L
13 Oct5L
12 Oct0L
9 Oct1L
8 Oct5L
7 Oct1L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
INDRAPRASTHA MEDICAL CORP
Healthcare Services
Add Stock
Add Another

INDRAPRASTHA MEDICAL CORP Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.